Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aim Immunotech, Ardigen, Bayer, Bharat, Celmatix, Eagle, Esperovax, Evotec, Freeline, Genmab, Halozyme, Hovione, Humanigen, Insysbio, J&J, Javelin, Ligand, Macrogenics, Manhattan Biosolutions, Medicinova, Minoryx, Mymetics, Nascent, Neurelis, Oncimmune, Pascal, Pfizer, Precision Virologics, Predictive Oncology, Puretech, Roche, Seelos, Sperogenix, Sumitomo, Symbio, Thermo Fisher, Trippbio, Tumorgenesis, Vivet, and Ximbio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AC Immune, Actinium, Afimmune, Bridge, Clearside, Cytokinetics, Dr. Reddy's, Durect, Enterome, Genentech, J&J, Macrogenics, Morphic, Neximmune, Nicox, Oncimmune, Selecta, Sobi, Takeda, Verona, Vtv.

Biopharmas raising money in public or private financings, including: Adicet, Athira, Avvinity, Biovie, Compass, Immetas, Immvira, Metabolon, Pureos, Recce, Rockwell, Saniona, Sernova, Silverback, Wave, Zogenix.

New hires and promotions in the biopharma industry, including: 4D Pharma, Celmatix, Escient, Leo.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Allovir, Ampio, Arca, AVM, Celltrion, Eisai, Epimab, Equillium, Harbour Biomed, Hutchison China Meditech, I-Mab, Junshi, Mateon, Morphosys, Sorrento, Takeda.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: 3D Medicines, Aim Immunotech, Algernon, Alphamab Oncology, Aslan, Astellas, Astrazeneca, Atossa, Atyr, Beigene, Clinuvel, Direct Biologics, Eli Lilly, Galera, Kyorin, Leap, Onconova, Opko Health, Rigel, Roche, Tracon.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Abound, Alaxia, Amgen, Axon, Betterlife, Biontech, Bristol Myers Squibb, C3.ai, Cebina, Cend, Dr. Reddy’s, Dyadic International, Eisai, Eli Lilly, Emergex, Eyevance, Fosun, Foundation Medicine, Generex, Genexine, Hepion, Hoth, Humanigen, Immunoprecise, Impilo, Janone, Jiangsu Hengrui Medicine, Junshi, Kiadis, Lonza, Mabion, Melior, Mylan, Nanoviricides, Neurorx, Novartis, Novavax, Octimet, Panolos, Pfizer, Pharmajet, Raziel, Relief, Revive, Samsung Biologics, Santen, Shanghai Fosun, Takeda, Teva, Tianjin Juvestar, Tiziana Life Sciences, Tonix, Transcenta Biomedical (Shanghai), Ufovax, Vaxine, Wigen Biomedicine, Xbiotech, Yufan, Zymeworks.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Humanigen, Xwpharma, Zai Lab.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Brii Biosciences, Sumitomo Dainippon.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alsa Ventures, Arrow Electronics, Avricore Health, Boeing, Cloud Dx, Detectachem, Elitechgroup, Healthe, MDx, Medigate, Neo Medical, Orthofix, Renalytix AI, Second Sight, Todos, Transmed7, Vivalnk.